Efficacy and Safety Study of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)

ClinicalTrials.gov ID: NCT07179380

Public ClinicalTrials.gov record NCT07179380. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced Oct 17, 2026, 1:56 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3, Randomized, Double-blind, Placebo-controlled, Multicenter, Parallel Group Study to Evaluate the Efficacy and Safety of Treprostinil Palmitil Inhalation Powder in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The primary objective of this study is to evaluate the effect of 24-weeks of once daily treatment with TPIP versus placebo on exercise capacity in adults with PH-ILD.

Study identification

NCT ID: NCT07179380
Recruitment status: Recruiting
Study type: Interventional
Phase: Phase 3
Lead sponsor: Insmed Incorporated; Industry
Enrollment: 344 participants

Conditions and interventions

Conditions

Interventions

Treprostinil Palmitil Inhalation Powder Drug
Placebo Drug

Drug

Eligibility (public fields only)

Age range: 18 Years and older
Sex: All
Healthy volunteers: Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Jan 7, 2026 (Actual)
Primary completion: Dec 30, 2028 (Estimated)
Completion: Dec 30, 2028 (Estimated)
Last update posted: Oct 13, 2026

2026 – 2028

United States locations

U.S. sites: 19
U.S. states: 11
U.S. cities: 18

Facility	City	State	ZIP	Site status
USA027	Phoenix	Arizona	85013	Not yet recruiting
USA007	Fresno	California	93720	Not yet recruiting
USA010	Los Angeles	California	900275969	Not yet recruiting
USA023	Los Angeles	California	90095	Recruiting
USA020	San Francisco	California	94143	Recruiting
USA001	Santa Barbara	California	93105-4349	Recruiting
USA017	Gainesville	Florida	32610	Recruiting
USA006	Naples	Florida	34102-5412	Recruiting
USA026	St. Petersburg	Florida	33707-6129	Recruiting
USA028	Tampa	Florida	33606	Not yet recruiting
USA002	Kansas City	Kansas	66160	Recruiting
USA005	New York	New York	10016	Recruiting
USA022	Chapel Hill	North Carolina	27599	Not yet recruiting
USA011	Durham	North Carolina	27710	Recruiting
USA015	Cincinnati	Ohio	45267	Recruiting
USA003	Bend	Oregon	97701	Recruiting
USA013	Philadelphia	Pennsylvania	19140	Recruiting
USA025	Salt Lake City	Utah	84018	Not yet recruiting
USA008	Richmond	Virginia	23230	Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 167 non-U.S. sites.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT07179380, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Oct 13, 2026 · Synced Oct 17, 2026

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT07179380 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →